curacle co., ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 2016-01-01
- Employees
- 34
- Market Cap
- -
- Website
- http://www.curacle.com
Clinical Trials
4
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (75.0%)Phase 1
1 (25.0%)Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis
- First Posted Date
- 2023-06-18
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Curacle Co., Ltd.
- Target Recruit Count
- 45
- Registration Number
- NCT05907330
Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Curacle Co., Ltd.
- Target Recruit Count
- 240
- Registration Number
- NCT05718375
- Locations
- 🇰🇷
Yeongnam University Medical Center, Daegu, Korea, Republic of
The Study of CU06-1004 in Patients With Diabetic Macular Edema (DME)
- First Posted Date
- 2022-10-10
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Curacle Co., Ltd.
- Target Recruit Count
- 67
- Registration Number
- NCT05573100
- Locations
- 🇺🇸
Rand Eye Institute, Deerfield Beach, Florida, United States
🇺🇸Elman Retina Group, Baltimore, Maryland, United States
🇺🇸Cumberland Valley Retina Consultants, Hagerstown, Maryland, United States
First-In-Human Study of CU06-1004 Following Single and Multiple Ascending Doses in Healthy Volunteers
Phase 1
Completed
- Conditions
- Diabetic Macular Edema
- Interventions
- Drug: PlaceboDrug: CU06-1004, Multiple dosesDrug: CU06-1004, Single dose
- First Posted Date
- 2021-03-12
- Last Posted Date
- 2022-07-21
- Lead Sponsor
- Curacle Co., Ltd.
- Target Recruit Count
- 81
- Registration Number
- NCT04795037
- Locations
- 🇺🇸
Celerion, Lincoln, Nebraska, United States
News
No news found